Albireo Pharma IncのIPO年
Albireo Pharma IncのIPO年は何ですか。
Albireo Pharma IncのIPO年は2016です。
IPO年の定義は何ですか。
新規公開株 (IPO)は、企業の株式を通常は機関投資家に販売し、順番に証券取引所で一般市民に販売する株式公開の一種です。
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
NASDAQのセクタHealth CareにおけるIPO年の企業と比べるAlbireo Pharma Inc
Albireo Pharma Incは何をしますか。
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Albireo Pharma Incと類似のipo年
- The Toronto-Dominion Bank PFD SER 9 3.7%のIPO年は2015です。
- Fura GemsのIPO年は2015です。
- Hostess BrandsのIPO年は2015です。
- Nabriva Therapeutics PlcのIPO年は2015です。
- REFのIPO年は2015です。
- H-SourceのIPO年は2015です。
- Albireo Pharma IncのIPO年は2016です。
- American Pacific BoratesのIPO年は2017です。
- RazerのIPO年は2017です。
- DEAG Deutsche Entertainment AktiengesellschaftのIPO年は2017です。
- Hamilton Beach Brands CoのIPO年は2017です。
- Artelo BiosciencesのIPO年は2017です。
- VARTA AGのIPO年は2017です。